Respiratory Monitoring Market: Global Industry Insights, Trends, Growth Factors and Faced By Key Vendors – COVIDIEN, GE HEALTHCARE, PHILIPS HEALTHCARE, SIEMENS HEALTHCARE, RESMED, DRAEGERWERK, CALONDO PHARMACEUTICALS

The respiratory monitoring market is expected to witness a CAGR of 9.5%, during the forecast period. North America has been accounted for the largest share in the global market in 2017 and it is expected to grow at the considerable rate in the upcoming future.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/17007
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rising Prevalence of Respiratory Diseases
The respiratory diseases, such as asthma, lung cancer, COPDs, are increasing at an alarming rate in both the developed and developing countries, which is driving the respiratory monitoring market globally. Based on the data from Centers for Disease Control and Prevention (CDC), around 25 million Americans have been found affected by asthma, in that 7.6 percent are adults and 8.4 percent are children. In 2015, 47.5 percent of children, aged 18 and younger, who had asthma reported having one or more asthma attacks in the past year. Due to this, continuously increasing respiratory diseases is creating a demand for the early diagnosis of these diseases, which results in more usage of the respiratory devices. Hence, due to the rising prevalence of the respiratory diseases the market is likely to grow.
The other factors include the rapid growth in geriatric population, urbanization, and growing pollution levels, high prevalence of tobacco smoking and development of advanced technologies.

Key Developments in the Market
April 2017 - ResMed launched AirMini, the world's smallest CPAP machine for the treatment of sleep apnea

Major Players-
COVIDIEN, GE HEALTHCARE, PHILIPS HEALTHCARE, SIEMENS HEALTHCARE, RESMED, MERCK & CO. INC., DRAEGERWERK, CALONDO PHARMACEUTICALS INC. AND QUARK PHARMACEUTICALS INC., amongst others.

Get Quality Discount @ https://marketprognosis.com/discount-request/17007
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Price of the Monitoring Devices
The average cost of the respiratory medical devices is generally between USD 2000- 5000. Due to the high cost, the low-income countries cannot afford these respiratory equipment’s. Hence, the cost of acquiring the respiratory medical devices is very high, considering the fact that a single device is not sufficient per hospital. The maintenance costs and service contracts are also very high for these devices. Therefore, due to this increasing price the mass adoption is being restricted, which is likely to impede the growth of this market. The other factor also includes the reimbursement concerns.

North America Dominates the Market
North America dominates the global respiratory monitoring market due to the high medical reimburstments facilities, and the increasing technological advancements. Asia Pacific is also, projected to have the fastest growth owing to the rapidly increasing aging population, rise in the consumer awareness and the growing of the medical tourism in the developing nations, such as China and India in this region.

Browse Report @ https://marketprognosis.com/enquiry/17007
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.